 |
인쇄하기
취소
|
Hyundai Pharm launches once-daily escitalopram formulation
Hyundai Pharm said on April 15 it launched an once-daily oral escitalopram tablet, aiming to boost sales in the local market.
The company is seeking to expand its presence in the local antidepressant medication market.
Escitalopram is noted for its high selectivity of serotonin reuptake inhibition and as a result has fewer side effects not related to its serotonergic activity.
Escital...
The company is seeking to expand its presence in the local antidepressant medication market.
Escitalopram is noted for its high selectivity of serotonin reuptake inhibition and as a result has fewer side effects not related to its serotonergic activity.
Escital...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.